The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...

After nearly three years as CFO of Lifeward, Michael Lawless will retire from his role at the Marlborough-based mobility device manufacturer in late June. Effective June 27, Lawless will resign from ...

This article first appeared on GuruFocus. Lifeward Ltd (NASDAQ:LFWD) is set to release its Q3 2025 earnings on Nov 14, 2025. The consensus estimate for Q3 2025 revenue is $6.31 million, and the ...

Days after Lifeward completed an approximately $47-million acquisition, the Marlborough-based mobility device manufacturer secured $20 million in capital funding. Lifeward issued a combination of ...

View Lifeward Ltd. LFWD stock quote prices, financial information, real-time forecasts, and company news from CNN.

MARLBOROUGH, Mass. and YOKNEAM ILLIT, Israel, Aug. 07, 2025 (GLOBE NEWSWIRE) -- Lifeward Ltd. (Nasdaq: LFWD) (“Lifeward” or the “Company”), a global leader in innovative medical technology to ...

HUDSON, Mass. and YOKNEAM ILLIT, Israel, March 13, 2026 (GLOBE NEWSWIRE) -- Lifeward Ltd. (Nasdaq: LFWD) (“Lifeward” or the “Company”), a global leader in innovative medical technology to transform ...

Lifeward Ltd. (NASDAQ:LFWD) stock is trading higher on Thursday after the company announced that its ReWalk 7 received 510(k) clearance from the Food and Drug Administration (FDA). What To Know: The ...

MARLBOROUGH, Mass. and YOKNEAM ILLIT, Israel, Feb. 19, 2025 (GLOBE NEWSWIRE) -- Lifeward Ltd. (Nasdaq: LFWD) (“Lifeward” or the “Company”), a global leader in innovative medical technology to ...

Lifeward (LFWD) has entered into a definitive agreement for the issuance and sale of an aggregate of 1,818,183 of the Company’s ordinary shares at a purchase price of $2.75 per share in a registered ...

HUDSON, Mass. and YOKNEAM ILLIT, Israel, March 25, 2026 (GLOBE NEWSWIRE)-- Lifeward Ltd. (Nasdaq: LFWD) (“Lifeward” or the “Company”), a global leader in innovative medical technology to transform the ...

Up to $47 million strategic investment from Oramed and another investor is intended to provide Lifeward cash runway to profitability and diversify its portfolio across MedTech and BioTech Lifeward ...